SCHEMBL22110944

SCHEMBL22110944

C=C1C(CO)CC1n1cnc2c(=O)[nH]c(N)nc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 1/20 0.52
▸ HPRT1 P00492 2/20 0.49
▸ TK1 P04183 2/20 0.47
▸ PNP P00491 3/20 0.46
▸ BLM P54132 2/20 0.46
▸ USP2 O75604 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ EDNRA P25101 1/20 0.46
▸ HTR2A P28223 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ HBB P68871 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ MEN1 O00255 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ NFKB1 P19838 1/20 0.45
▸ VCP P55072 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24257989 1.00 ADORA3 (0.52) ADORA3HPRT1TK1PNPBLM
SCHEMBL18516930 0.90 ADORA3 (0.51) ADORA3HPRT1TK1PNPBLM
SCHEMBL15197991 0.90 ADORA3 (0.51) ADORA3HPRT1TK1PNPBLM
SCHEMBL880159 0.90 ADORA3 (0.51) ADORA3HPRT1TK1PNPBLM
Entecavir Anhydrous SCHEMBL21347868 0.86 ADORA3 (0.52) ADORA3HPRT1TK1PNPBLM
SCHEMBL9223882 0.86 ADORA3 (0.52) ADORA3HPRT1TK1PNPBLM
Entecavir Anhydrous SCHEMBL28648 0.86 ADORA3 (0.52) ADORA3HPRT1TK1PNPBLM
Entecavir Anhydrous SCHEMBL21510623 0.86 ADORA3 (0.52) ADORA3HPRT1TK1PNPBLM
Entecavir Anhydrous SCHEMBL24726395 0.86 ADORA3 (0.52) ADORA3HPRT1TK1PNPBLM
Entecavir Anhydrous SCHEMBL19644968 0.86 ADORA3 (0.52) ADORA3HPRT1TK1PNPBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020121122-A1 CYCLOBUTYL NUCLEOSIDE ANALOGS AS ANTI-VIRALS Janssen Biopharma, Inc. (US) 2020-06-18 — — WO disclosed
Send feedback